Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.06 trillion and total revenue of $110.13 billion.
Market Cap
1.06T
Revenue
110.13B
Profits
-41.73B
PE Ratio
n/a
Profit Margin
-37.89%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 119.23B | -1.84% | 1,097,300 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.84B | -0.11% | 438,133 | 14.34B |
| 3 | ARGX | argenx SE | 42.84B | -1.19% | 298,407 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.57B | -1.20% | 825,002 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 31.49B | -0.44% | 229,085 | 5.34B |
| 6 | INSM | Insmed Incorporated | 30.07B | -0.01% | 1,480,821 | 606.42M |
| 7 | BNTX | BioNTech SE | 22.92B | 1.21% | 1,403,025 | 3.37B |
| 8 | MRNA | Moderna, Inc. | 20.76B | -1.55% | 6,604,639 | 1.94B |
| 9 | ROIV | Roivant Sciences Ltd. | 20.08B | -1.72% | 5,466,276 | 13.31M |
| 10 | RPRX | Royalty Pharma plc | 19.56B | -0.48% | 2,682,076 | 2.38B |
| 11 | RVMD | Revolution Medicines, Inc. | 18.80B | -0.22% | 1,465,593 | - |
| 12 | INCY | Incyte Corporation | 18.42B | 0.55% | 1,682,183 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.79B | -1.62% | 1,032,906 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 13.87B | -1.32% | 603,957 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.46B | 2.10% | 1,811,380 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.50B | 4.27% | 2,655,825 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.76B | -1.59% | 1,972,033 | 943.71M |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.25B | -0.95% | 1,179,235 | 3.22B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 10.99B | -0.98% | 827,475 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 10.71B | 0.17% | 2,235,704 | 2.32B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.20B | 1.39% | 220,732 | 958.40M |
| 22 | ABVX | ABIVAX Société Anonyme | 8.99B | -1.27% | 700,981 | 6.23M |
| 23 | IBRX | ImmunityBio, Inc. | 8.63B | 7.29% | 30,623,277 | 113.29M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.19B | -3.11% | 500,820 | 7.46M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 7.98B | 1.27% | 854,164 | 638.50M |
| 26 | TECH | Bio-Techne Corporation | 7.96B | -1.20% | 2,439,215 | 1.22B |
| 27 | PCVX | Vaxcyte, Inc. | 7.86B | -2.90% | 1,394,794 | - |
| 28 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.71B | 0.07% | 4,466,022 | 1.09B |
| 29 | NUVL | Nuvalent, Inc. | 7.70B | -0.07% | 752,413 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.51B | 0.16% | 1,133,960 | 1.40B |
| 31 | CYTK | Cytokinetics, Incorporated | 7.40B | 0.09% | 1,933,934 | 88.04M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.23B | -1.61% | 286,637 | 389.13M |
| 33 | ACLX | Arcellx, Inc. | 6.69B | 0.09% | 816,491 | 22.29M |
| 34 | BLTE | Belite Bio, Inc | 6.46B | -3.25% | 109,687 | - |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.45B | 1.97% | 416,879 | 39.21M |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.97B | -4.14% | 1,620,714 | 189.76M |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 5.89B | -3.21% | 895,715 | 46.02M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.52B | -3.76% | 1,647,208 | - |
| 39 | MIRM | Mirum Pharmaceuticals, Inc. | 5.47B | 0.98% | 505,637 | 521.31M |
| 40 | CGON | CG Oncology, Inc. | 5.43B | 2.10% | 1,879,753 | 4.04M |
| 41 | PTCT | PTC Therapeutics, Inc. | 5.34B | 1.78% | 605,685 | 1.73B |
| 42 | CELC | Celcuity Inc. | 5.29B | 3.11% | 434,599 | - |
| 43 | XENE | Xenon Pharmaceuticals Inc. | 5.27B | -4.61% | 3,849,818 | 7.50M |
| 44 | CAI | Caris Life Sciences, Inc. | 5.13B | 2.60% | 1,690,559 | 812.03M |
| 45 | APGE | Apogee Therapeutics, Inc. | 5.00B | -2.19% | 725,690 | - |
| 46 | IMVT | Immunovant, Inc. | 4.97B | -2.32% | 1,106,627 | - |
| 47 | CRSP | CRISPR Therapeutics AG | 4.68B | -0.25% | 1,972,313 | 3.51M |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.60B | -4.28% | 1,084,897 | - |
| 49 | FOLD | Amicus Therapeutics, Inc. | 4.51B | 0.03% | 2,738,133 | 634.21M |
| 50 | TGTX | TG Therapeutics, Inc. | 4.46B | 3.79% | 1,891,872 | 616.29M |
| 51 | ERAS | Erasca, Inc. | 4.23B | -7.03% | 5,345,475 | - |
| 52 | TERN | Terns Pharmaceuticals, Inc. | 4.19B | 5.15% | 4,243,968 | - |
| 53 | VKTX | Viking Therapeutics, Inc. | 4.12B | 0.45% | 2,782,664 | - |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.05B | -4.05% | 273,303 | 268.09M |
| 55 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.93B | 2.68% | 956,506 | 7.70M |
| 56 | GPCR | Structure Therapeutics Inc. | 3.81B | -1.52% | 587,512 | - |
| 57 | ADMA | ADMA Biologics, Inc. | 3.61B | 1.07% | 2,863,937 | 510.17M |
| 58 | CNTA | Centessa Pharmaceuticals plc | 3.54B | -3.27% | 1,362,214 | 15.00M |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 3.51B | -3.10% | 1,546,773 | 1.07B |
| 60 | LEGN | Legend Biotech Corporation | 3.47B | -1.57% | 1,417,876 | 1.03B |
| 61 | DNTH | Dianthus Therapeutics, Inc. | 3.46B | -3.06% | 2,300,438 | 2.04M |
| 62 | CORT | Corcept Therapeutics Incorporated | 3.42B | -0.74% | 1,018,901 | 761.41M |
| 63 | NAMS | NewAmsterdam Pharma Company N.V. | 3.29B | -4.02% | 964,952 | 22.50M |
| 64 | DNLI | Denali Therapeutics Inc. | 3.26B | -0.63% | 1,290,238 | - |
| 65 | EWTX | Edgewise Therapeutics, Inc. | 3.17B | -1.17% | 702,188 | - |
| 66 | SYRE | Spyre Therapeutics, Inc. | 3.13B | -1.29% | 844,837 | - |
| 67 | DYN | Dyne Therapeutics, Inc. | 2.96B | -0.78% | 2,445,233 | - |
| 68 | VRDN | Viridian Therapeutics, Inc. | 2.93B | 0.95% | 1,131,572 | 70.85M |
| 69 | IDYA | IDEAYA Biosciences, Inc. | 2.91B | 0.79% | 812,849 | 218.71M |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 2.89B | -0.31% | 296,368 | 451.36M |
| 71 | VERA | Vera Therapeutics, Inc. | 2.85B | -2.94% | 1,510,562 | - |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.84B | -0.68% | 1,023,978 | 588.99M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.82B | -0.70% | 885,558 | 376.07M |
| 74 | RCUS | Arcus Biosciences, Inc. | 2.75B | -3.22% | 1,173,170 | 247.00M |
| 75 | TLX | Telix Pharmaceuticals Limited | 2.66B | -0.51% | 120,049 | 803.79M |
| 76 | ALMS | Alumis Inc. | 2.59B | -0.88% | 1,286,634 | 22.12M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.56B | 0.91% | 741,993 | 490.73M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.56B | -1.68% | 1,655,453 | 139.74M |
| 79 | TNGX | Tango Therapeutics, Inc. | 2.47B | 0.87% | 4,209,476 | 62.38M |
| 80 | WVE | Wave Life Sciences Ltd. | 2.45B | -2.47% | 2,830,246 | 42.73M |
| 81 | APLS | Apellis Pharmaceuticals, Inc. | 2.42B | 2.99% | 1,702,841 | 1.00B |
| 82 | MAZE | Maze Therapeutics, Inc. | 2.42B | -3.14% | 1,065,772 | 2.50M |
| 83 | IMNM | Immunome, Inc. | 2.30B | -3.00% | 983,594 | 6.94M |
| 84 | IRON | Disc Medicine, Inc. | 2.29B | 0.47% | 384,371 | - |
| 85 | AAPG | Ascentage Pharma Group International | 2.27B | 1.79% | 2,351 | 54.52M |
| 86 | DAWN | Day One Biopharmaceuticals, Inc. | 2.20B | 0.19% | 5,101,585 | 158.18M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.16B | -2.96% | 1,393,468 | - |
| 88 | NKTR | Nektar Therapeutics | 2.10B | 4.11% | 1,364,317 | 55.23M |
| 89 | GLPG | Galapagos NV | 2.09B | -0.69% | 177,040 | 1.31B |
| 90 | SNDX | Syndax Pharmaceuticals, Inc. | 2.07B | -2.04% | 1,677,646 | 172.35M |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.06B | -1.70% | 2,543,245 | 673.00M |
| 92 | ZLAB | Zai Lab Limited | 2.03B | -2.65% | 429,169 | 460.16M |
| 93 | ADPT | Adaptive Biotechnologies Corporation | 2.03B | 5.78% | 3,888,336 | 276.98M |
| 94 | ORKA | Oruka Therapeutics, Inc. | 1.98B | 25.04% | 1,610,216 | - |
| 95 | MANE | Veradermics, Incorporated | 1.97B | 2.39% | 282,373 | - |
| 96 | CLDX | Celldex Therapeutics, Inc. | 1.96B | -1.24% | 510,031 | 1.55M |
| 97 | TYRA | Tyra Biosciences, Inc. | 1.95B | 0.61% | 1,643,841 | - |
| 98 | OCUL | Ocular Therapeutix, Inc. | 1.91B | -1.24% | 3,723,569 | 51.95M |
| 99 | STOK | Stoke Therapeutics, Inc. | 1.90B | -9.02% | 1,821,184 | 205.63M |
| 100 | MESO | Mesoblast Limited | 1.87B | -3.45% | 253,767 | 65.38M |
| 101 | ANAB | AnaptysBio, Inc. | 1.86B | 1.60% | 786,855 | 234.60M |
| 102 | AUPH | Aurinia Pharmaceuticals Inc. | 1.85B | -2.92% | 997,014 | 283.06M |
| 103 | RLAY | Relay Therapeutics, Inc. | 1.85B | -1.80% | 1,632,150 | 15.36M |
| 104 | RXRX | Recursion Pharmaceuticals, Inc. | 1.80B | 3.95% | 14,401,197 | 74.68M |
| 105 | DFTX | Definium Therapeutics, Inc. | 1.80B | 0.44% | 1,628,634 | - |
| 106 | SLNO | Soleno Therapeutics, Inc. | 1.74B | -8.12% | 3,879,038 | 190.41M |
| 107 | SRPT | Sarepta Therapeutics, Inc. | 1.72B | -3.76% | 2,291,589 | 2.20B |
| 108 | ZYME | Zymeworks Inc. | 1.69B | -1.51% | 787,220 | 105.97M |
| 109 | SION | Sionna Therapeutics, Inc. | 1.68B | 1.74% | 320,314 | - |
| 110 | NVAX | Novavax, Inc. | 1.67B | -0.63% | 2,859,018 | 1.12B |
| 111 | GENB | Generate Biomedicines, Inc. | 1.67B | -1.51% | 695,634 | 31.89M |
| 112 | ELVN | Enliven Therapeutics, Inc. | 1.66B | -3.61% | 1,119,869 | - |
| 113 | VCEL | Vericel Corporation | 1.65B | 1.32% | 604,410 | 276.26M |
| 114 | INVA | Innoviva, Inc. | 1.63B | 0.27% | 650,027 | 411.33M |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 1.63B | 0.94% | 506,952 | 54.03M |
| 116 | IOVA | Iovance Biotherapeutics, Inc. | 1.63B | -2.70% | 19,358,836 | 263.50M |
| 117 | NBTX | Nanobiotix S.A. | 1.60B | 4.92% | 65,018 | 11.93M |
| 118 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | -0.65% | 478,664 | 868.45M |
| 119 | IMCR | Immunocore Holdings plc | 1.56B | -0.58% | 322,616 | 400.02M |
| 120 | NRIX | Nurix Therapeutics, Inc. | 1.55B | -3.65% | 757,288 | 83.98M |
| 121 | NUVB | Nuvation Bio Inc. | 1.54B | 1.60% | 3,711,357 | 62.90M |
| 122 | NTLA | Intellia Therapeutics, Inc. | 1.51B | -0.70% | 2,853,784 | 67.67M |
| 123 | OCS | Oculis Holding AG | 1.50B | -6.16% | 585,449 | 1.51M |
| 124 | PVLA | Palvella Therapeutics, Inc. | 1.44B | -10.64% | 521,105 | - |
| 125 | BHVN | Biohaven Ltd. | 1.44B | -3.33% | 1,737,026 | - |
| 126 | ARDX | Ardelyx, Inc. | 1.42B | 2.12% | 2,740,171 | 407.32M |
| 127 | TRVI | Trevi Therapeutics, Inc. | 1.41B | -1.70% | 984,177 | - |
| 128 | CAPR | Capricor Therapeutics, Inc. | 1.39B | -8.74% | 2,589,733 | 11.13M |
| 129 | PHVS | Pharvaris N.V. | 1.39B | -3.64% | 99,067 | - |
| 130 | ATAI | AtaiBeckley Inc. | 1.34B | -3.40% | 4,170,501 | 4.09M |
| 131 | RAPP | Rapport Therapeutics, Inc. | 1.33B | -2.90% | 401,211 | - |
| 132 | MBX | MBX Biosciences, Inc. | 1.33B | 0.18% | 728,537 | - |
| 133 | VIR | Vir Biotechnology, Inc. | 1.29B | -2.32% | 2,612,516 | 68.56M |
| 134 | ZBIO | Zenas BioPharma, Inc. | 1.29B | -2.04% | 491,524 | 15.00M |
| 135 | CRVS | Corvus Pharmaceuticals, Inc. | 1.29B | -4.31% | 1,221,429 | - |
| 136 | PGEN | Precigen, Inc. | 1.24B | 7.01% | 2,802,079 | 6.31M |
| 137 | IMTX | Immatics N.V. | 1.24B | -1.81% | 259,421 | 56.67M |
| 138 | KOD | Kodiak Sciences Inc. | 1.23B | -2.52% | 381,164 | - |
| 139 | TSHA | Taysha Gene Therapies, Inc. | 1.23B | -2.60% | 5,042,561 | 6.31M |
| 140 | MLTX | MoonLake Immunotherapeutics | 1.23B | 0.59% | 678,574 | - |
| 141 | ORIC | ORIC Pharmaceuticals, Inc. | 1.19B | 1.19% | 1,579,512 | - |
| 142 | SEPN | Septerna, Inc. | 1.13B | -4.95% | 282,794 | 45.95M |
| 143 | EYPT | EyePoint, Inc. | 1.10B | -5.92% | 1,238,163 | 31.37M |
| 144 | TVGN | Tevogen Bio Holdings Inc. | 1.09B | -15.67% | 130,393 | - |
| 145 | SVRA | Savara Inc. | 1.07B | -1.32% | 2,224,830 | - |
| 146 | ABCL | AbCellera Biologics Inc. | 1.06B | 0.58% | 2,062,966 | 75.13M |
| 147 | AVBP | ArriVent BioPharma, Inc. | 1.06B | -0.83% | 262,385 | - |
| 148 | BCAX | Bicara Therapeutics Inc. | 1.05B | -0.10% | 346,887 | - |
| 149 | GLUE | Monte Rosa Therapeutics, Inc. | 1.04B | -0.12% | 834,056 | 181.54M |
| 150 | GERN | Geron Corporation | 1.01B | -1.25% | 13,663,998 | 183.88M |
| 151 | OLMA | Olema Pharmaceuticals, Inc. | 1.01B | -1.34% | 1,259,017 | - |
| 152 | INBX | Inhibrx Biosciences, Inc. | 999.74M | -0.81% | 137,686 | 1.40M |
| 153 | AKTS | Aktis Oncology, Inc. | 997.40M | 3.83% | 283,602 | 5.56M |
| 154 | PHAR | Pharming Group N.V. | 994.15M | -4.23% | 35,942 | 376.13M |
| 155 | QURE | uniQure N.V. | 971.08M | -8.32% | 2,996,603 | 16.10M |
| 156 | XERS | Xeris Biopharma Holdings, Inc. | 941.47M | -0.36% | 1,468,749 | 291.85M |
| 157 | CMPX | Compass Therapeutics, Inc. | 934.66M | - | 1,058,339 | 850.00K |
| 158 | GHRS | GH Research PLC | 927.34M | -3.67% | 117,861 | - |
| 159 | VALN | Valneva SE | 911.69M | 1.24% | 11,815 | 211.09M |
| 160 | URGN | UroGen Pharma Ltd. | 897.70M | -1.81% | 786,183 | 109.79M |
| 161 | SANA | Sana Biotechnology, Inc. | 896.67M | 8.74% | 4,554,138 | - |
| 162 | SGP | SpyGlass Pharma, Inc. | 884.58M | 0.49% | 101,929 | - |
| 163 | ANL | Adlai Nortye Ltd. | 880.07M | -4.90% | 154,230 | -1.35M |
| 164 | XNCR | Xencor, Inc. | 880.06M | 3.36% | 646,477 | 125.58M |
| 165 | KALV | KalVista Pharmaceuticals, Inc. | 856.25M | -2.53% | 844,236 | 1.43M |
| 166 | MNKD | MannKind Corporation | 853.44M | -1.77% | 3,814,320 | 348.97M |
| 167 | FTRE | Fortrea Holdings Inc. | 834.96M | -1.11% | 1,413,145 | 2.72B |
| 168 | IVA | Inventiva S.A. | 833.52M | -2.92% | 141,750 | 19.93M |
| 169 | SPRY | ARS Pharmaceuticals, Inc. | 833.10M | 1.82% | 1,041,476 | 84.28M |
| 170 | MPLT | MapLight Therapeutics, Inc. | 832.24M | -0.37% | 140,077 | - |
| 171 | JANX | Janux Therapeutics, Inc. | 826.09M | -2.65% | 1,084,125 | 10.00M |
| 172 | ABUS | Arbutus Biopharma Corporation | 819.30M | -1.39% | 1,485,366 | 14.61M |
| 173 | PHAT | Phathom Pharmaceuticals, Inc. | 817.14M | 1.47% | 1,258,278 | 175.11M |
| 174 | CGEM | Cullinan Therapeutics, Inc. | 816.50M | -3.30% | 707,283 | - |
| 175 | OCGN | Ocugen, Inc. | 813.19M | 5.98% | 15,475,184 | 4.41M |
| 176 | OMER | Omeros Corporation | 793.38M | -2.01% | 749,717 | - |
| 177 | CTMX | CytomX Therapeutics, Inc. | 792.96M | -3.90% | 2,861,038 | 113.63M |
| 178 | EVMN | Evommune, Inc. | 792.04M | -4.31% | 238,964 | 13.00M |
| 179 | ARVN | Arvinas, Inc. | 779.04M | -2.40% | 684,975 | 262.60M |
| 180 | SLS | SELLAS Life Sciences Group, Inc. | 764.91M | 6.76% | 6,103,555 | - |
| 181 | KURA | Kura Oncology, Inc. | 764.05M | -2.15% | 1,285,222 | 67.48M |
| 182 | GYRE | Gyre Therapeutics, Inc. | 732.56M | -3.27% | 138,329 | 116.59M |
| 183 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 727.50M | -0.44% | 191,500 | - |
| 184 | DRUG | Bright Minds Biosciences Inc. | 719.99M | -0.35% | 197,173 | - |
| 185 | LXRX | Lexicon Pharmaceuticals, Inc. | 716.02M | -1.74% | 2,245,537 | 49.80M |
| 186 | TBPH | Theravance Biopharma, Inc. | 698.27M | -0.79% | 579,438 | 80.33M |
| 187 | ANRO | Alto Neuroscience, Inc. | 691.54M | 0.13% | 263,863 | - |
| 188 | JBIO | Jade Biosciences, Inc. | 686.48M | 0.43% | 208,823 | - |
| 189 | ANNX | Annexon, Inc. | 677.12M | 4.04% | 1,594,057 | - |
| 190 | PROK | ProKidney Corp. | 676.88M | 0.45% | 584,326 | 744.00K |
| 191 | AGMB | AgomAb Therapeutics NV | 675.00M | -0.43% | 38,022 | - |
| 192 | PRME | Prime Medicine, Inc. | 659.02M | -2.14% | 2,216,172 | 4.63M |
| 193 | MDXG | MiMedx Group, Inc. | 650.72M | - | 648,305 | 418.63M |
| 194 | LBRX | LB Pharmaceuticals Inc | 649.43M | 2.93% | 296,343 | - |
| 195 | DRTS | Alpha Tau Medical Ltd. | 631.03M | 2.87% | 152,588 | - |
| 196 | TECX | Tectonic Therapeutic, Inc. | 625.45M | -2.37% | 270,256 | - |
| 197 | DSGN | Design Therapeutics, Inc. | 624.12M | 1.00% | 337,804 | - |
| 198 | EIKN | Eikon Therapeutics, Inc. | 618.66M | -2.72% | 500,803 | - |
| 199 | MGTX | MeiraGTx Holdings plc | 594.83M | -3.27% | 270,515 | 27.42M |
| 200 | REPL | Replimune Group, Inc. | 589.57M | -5.80% | 2,159,244 | - |
| 201 | ZVRA | Zevra Therapeutics, Inc. | 585.94M | -2.06% | 1,050,454 | 106.47M |
| 202 | ALLO | Allogene Therapeutics, Inc. | 585.07M | -2.83% | 4,975,646 | 22.00K |
| 203 | SLDB | Solid Biosciences Inc. | 569.52M | -5.19% | 2,041,283 | - |
| 204 | DBVT | DBV Technologies S.A. | 561.96M | 2.59% | 400,100 | 5.50M |
| 205 | ADCT | ADC Therapeutics SA | 524.69M | -5.06% | 815,860 | 81.36M |
| 206 | VNDA | Vanda Pharmaceuticals Inc. | 520.74M | -5.17% | 1,588,181 | 216.11M |
| 207 | RCKT | Rocket Pharmaceuticals, Inc. | 513.53M | -3.86% | 1,826,958 | - |
| 208 | YDES | YD Bio Limited | 513.33M | -2.80% | 7,300 | 510.36K |
| 209 | CRMD | CorMedix Inc. | 509.88M | 0.78% | 1,899,262 | 311.71M |
| 210 | FULC | Fulcrum Therapeutics, Inc. | 509.49M | 0.26% | 536,827 | 80.00M |
| 211 | NMRA | Neumora Therapeutics, Inc. | 501.27M | -4.46% | 656,314 | - |
| 212 | UPB | Upstream Bio, Inc. | 498.78M | -2.22% | 723,097 | 2.80M |
| 213 | PRTA | Prothena Corporation plc | 495.80M | -1.07% | 584,453 | 9.68M |
| 214 | LYEL | Lyell Immunopharma, Inc. | 495.28M | -14.25% | 141,870 | 36.00K |
| 215 | VSTM | Verastem, Inc. | 491.88M | -4.11% | 2,042,156 | 30.91M |
| 216 | IVVD | Invivyd, Inc. | 491.71M | -3.33% | 2,683,523 | 53.43M |
| 217 | LXEO | Lexeo Therapeutics, Inc. | 486.10M | 0.45% | 1,777,739 | - |
| 218 | AVIR | Atea Pharmaceuticals, Inc. | 486.00M | - | 507,416 | - |
| 219 | TRDA | Entrada Therapeutics, Inc. | 485.83M | -2.23% | 137,222 | 25.42M |
| 220 | CTNM | Contineum Therapeutics, Inc. | 485.37M | -6.13% | 228,111 | - |
| 221 | ENGN | enGene Holdings Inc. | 479.64M | -1.92% | 791,216 | - |
| 222 | RIGL | Rigel Pharmaceuticals, Inc. | 479.38M | -2.44% | 415,908 | 294.28M |
| 223 | ALT | Altimmune, Inc. | 455.24M | -2.78% | 3,103,154 | 41.00K |
| 224 | MRVI | Maravai LifeSciences Holdings, Inc. | 450.86M | -6.38% | 1,713,819 | 185.74M |
| 225 | ASMB | Assembly Biosciences, Inc. | 444.70M | -0.48% | 67,093 | 37.19M |
| 226 | EPRX | Eupraxia Pharmaceuticals Inc. | 444.15M | -1.87% | 110,699 | - |
| 227 | RGNX | REGENXBIO Inc. | 442.32M | -5.62% | 1,057,960 | 170.44M |
| 228 | RLMD | Relmada Therapeutics, Inc. | 433.40M | -3.90% | 1,266,747 | - |
| 229 | AVXL | Anavex Life Sciences Corp. | 430.92M | - | 987,553 | - |
| 230 | STTK | Shattuck Labs, Inc. | 428.67M | -2.28% | 354,476 | 1.00M |
| 231 | ACRS | Aclaris Therapeutics, Inc. | 426.91M | 0.85% | 897,828 | 7.83M |
| 232 | FDMT | 4D Molecular Therapeutics, Inc. | 424.90M | -1.42% | 465,682 | 120.00K |
| 233 | IPSC | Century Therapeutics, Inc. | 420.55M | -6.40% | 1,248,302 | 109.16M |
| 234 | BNTC | Benitec Biopharma Inc. | 403.66M | -3.05% | 130,964 | - |
| 235 | MNPR | Monopar Therapeutics Inc. | 403.36M | 4.79% | 335,124 | - |
| 236 | ZURA | Zura Bio Limited | 401.19M | -9.13% | 341,023 | - |
| 237 | LCTX | Lineage Cell Therapeutics, Inc. | 401.03M | 1.90% | 1,398,552 | 14.56M |
| 238 | DNA | Ginkgo Bioworks Holdings, Inc. | 400.69M | 6.25% | 1,756,448 | 170.16M |
| 239 | PRTC | PureTech Health plc | 399.78M | -1.30% | 1,660 | 6.39M |
| 240 | LRMR | Larimar Therapeutics, Inc. | 393.29M | -3.67% | 3,841,698 | - |
| 241 | KYTX | Kyverna Therapeutics, Inc. | 391.98M | 2.05% | 561,105 | - |
| 242 | AUTL | Autolus Therapeutics plc | 383.25M | -1.37% | 1,515,870 | 51.13M |
| 243 | ARMP | Armata Pharmaceuticals, Inc. | 382.92M | -0.85% | 13,800 | 5.05M |
| 244 | NAGE | Niagen Bioscience, Inc. | 382.78M | -0.83% | 1,199,049 | 129.42M |
| 245 | LENZ | LENZ Therapeutics, Inc. | 380.17M | 2.79% | 749,776 | 17.50M |
| 246 | DMAC | DiaMedica Therapeutics Inc. | 379.12M | 0.55% | 240,634 | - |
| 247 | AURA | Aura Biosciences, Inc. | 377.21M | -0.17% | 325,294 | - |
| 248 | GLSI | Greenwich LifeSciences, Inc. | 370.47M | 0.75% | 160,235 | - |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 368.55M | -5.29% | 473,309 | 66.98M |
| 250 | PEPG | PepGen Inc. | 368.04M | -13.41% | 1,340,582 | - |
| 251 | ABSI | Absci Corporation | 359.39M | 3.91% | 2,489,891 | 2.82M |
| 252 | IRD | Opus Genetics, Inc. | 357.88M | 3.93% | 1,208,408 | 14.20M |
| 253 | CADL | Candel Therapeutics, Inc. | 342.06M | -6.22% | 1,360,630 | - |
| 254 | NERV | Minerva Neurosciences, Inc. | 338.84M | 1.82% | 243,610 | - |
| 255 | CLYM | Climb Bio, Inc. | 335.81M | -3.17% | 446,011 | - |
| 256 | IMMX | Immix Biopharma, Inc. | 335.78M | -1.09% | 607,698 | - |
| 257 | FBRX | Forte Biosciences, Inc. | 334.97M | -1.40% | 126,878 | - |
| 258 | NGNE | Neurogene Inc. | 333.19M | -3.54% | 258,954 | 925.00K |
| 259 | BCYC | Bicycle Therapeutics plc | 331.58M | -5.16% | 418,365 | 28.34M |
| 260 | IMRX | Immuneering Corporation | 326.50M | -7.34% | 1,517,933 | - |
| 261 | NBP | NovaBridge Biosciences | 326.27M | -3.74% | 462,255 | - |
| 262 | SLN | Silence Therapeutics plc | 325.91M | -1.58% | 227,468 | 559.00K |
| 263 | XFOR | X4 Pharmaceuticals, Inc. | 322.64M | -4.90% | 216,950 | 33.98M |
| 264 | XOMA | XOMA Royalty Corporation | 313.62M | -1.79% | 117,493 | 47.11M |
| 265 | CNTX | Context Therapeutics Inc. | 308.71M | 8.74% | 1,771,115 | - |
| 266 | CBIO | Crescent Biopharma, Inc. | 308.08M | -2.34% | 111,198 | 10.84M |
| 267 | ACIU | AC Immune SA | 306.85M | 0.83% | 255,109 | 4.51M |
| 268 | PLYX | Polaryx Therapeutics, Inc. | 301.10M | 36.77% | 7,834,360 | - |
| 269 | PBYI | Puma Biotechnology, Inc. | 300.17M | 0.34% | 250,420 | 228.37M |
| 270 | CABA | Cabaletta Bio, Inc. | 294.57M | -4.08% | 1,473,839 | - |
| 271 | NAUT | Nautilus Biotechnology, Inc. | 294.29M | 1.75% | 144,080 | - |
| 272 | PALI | Palisade Bio, Inc. | 289.07M | -4.43% | 3,104,998 | - |
| 273 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 288.62M | -6.79% | 225,612 | - |
| 274 | FHTX | Foghorn Therapeutics Inc. | 287.63M | -0.41% | 229,608 | 30.91M |
| 275 | AVTX | Avalo Therapeutics, Inc. | 286.52M | -5.45% | 314,151 | 192.00K |
| 276 | TARA | Protara Therapeutics, Inc. | 284.48M | -1.13% | 692,299 | - |
| 277 | CAMP | Camp4 Therapeutics Corporation | 280.88M | 0.56% | 107,578 | 3.50M |
| 278 | VYGR | Voyager Therapeutics, Inc. | 265.52M | -8.52% | 1,028,818 | 40.37M |
| 279 | CCCC | C4 Therapeutics, Inc. | 265.41M | -1.09% | 1,832,955 | 35.95M |
| 280 | CLLS | Cellectis S.A. | 260.64M | 2.70% | 33,719 | 82.55M |
| 281 | ALXO | ALX Oncology Holdings Inc. | 260.58M | -1.98% | 371,432 | - |
| 282 | OABI | OmniAb, Inc. | 259.16M | -3.24% | 187,708 | 18.67M |
| 283 | ABEO | Abeona Therapeutics Inc. | 257.95M | -3.94% | 1,057,713 | 400.00K |
| 284 | RZLT | Rezolute, Inc. | 248.34M | -14.07% | 3,280,875 | - |
| 285 | ALDX | Aldeyra Therapeutics, Inc. | 248.25M | -11.67% | 3,391,602 | - |
| 286 | OBIO | Orchestra BioMed Holdings, Inc. | 245.79M | -4.11% | 278,584 | 33.48M |
| 287 | CHRS | Coherus Oncology, Inc. | 244.32M | -3.55% | 1,164,051 | 42.17M |
| 288 | ALEC | Alector, Inc. | 242.80M | -1.35% | 644,994 | 21.05M |
| 289 | NVCT | Nuvectis Pharma, Inc. | 239.22M | 0.11% | 30,400 | - |
| 290 | EDIT | Editas Medicine, Inc. | 238.81M | -3.94% | 1,218,575 | 40.52M |
| 291 | TENX | Tenax Therapeutics, Inc. | 238.01M | -2.47% | 273,610 | - |
| 292 | SLGL | Sol-Gel Technologies Ltd. | 233.92M | -2.81% | 38,782 | 18.97M |
| 293 | HELP | Cybin Inc. | 232.17M | -9.55% | 1,587,875 | - |
| 294 | PLX | Protalix BioTherapeutics, Inc. | 227.59M | 1.43% | 705,602 | 61.84M |
| 295 | ELTX | Elicio Therapeutics, Inc. | 224.43M | 13.07% | 163,806 | - |
| 296 | ACHV | Achieve Life Sciences, Inc. | 221.99M | 0.72% | 355,557 | - |
| 297 | KROS | Keros Therapeutics, Inc. | 217.29M | 0.27% | 516,560 | 244.06M |
| 298 | HUMA | Humacyte, Inc. | 217.23M | 1.75% | 2,289,177 | 1.57M |
| 299 | SRZN | Surrozen, Inc. | 216.09M | -3.47% | 164,020 | 3.60M |
| 300 | MDWD | MediWound Ltd. | 212.81M | - | 27,470 | 16.96M |
| 301 | CGEN | Compugen Ltd. | 211.80M | 1.36% | 307,644 | 72.76M |
| 302 | SABS | SAB Biotherapeutics, Inc. | 211.45M | -9.59% | 577,465 | 114.70K |
| 303 | FENC | Fennec Pharmaceuticals Inc. | 211.44M | -1.44% | 90,018 | 38.79M |
| 304 | CNTN | Canton Strategic Holdings, Inc. | 209.68M | -2.98% | 505,504 | - |
| 305 | PRLD | Prelude Therapeutics Incorporated | 207.91M | -2.08% | 245,575 | 12.14M |
| 306 | CBUS | Cibus, Inc. | 199.76M | -3.07% | 437,703 | 3.79M |
| 307 | GALT | Galectin Therapeutics Inc. | 199.22M | -2.22% | 277,426 | - |
| 308 | ABOS | Acumen Pharmaceuticals, Inc. | 198.08M | -0.91% | 393,349 | - |
| 309 | STRO | Sutro Biopharma, Inc. | 196.49M | -5.60% | 96,005 | 105.65M |
| 310 | NTHI | NeOnc Technologies Holdings, Inc. | 196.29M | -3.89% | 70,150 | 59.99K |
| 311 | RNAC | Cartesian Therapeutics, Inc. | 195.90M | -8.99% | 150,703 | 2.80M |
| 312 | ZNTL | Zentalis Pharmaceuticals, Inc. | 195.80M | -1.45% | 396,778 | 26.87M |
| 313 | ADAG | Adagene Inc. | 194.65M | 16.01% | 386,975 | 103.20K |
| 314 | PRQR | ProQR Therapeutics N.V. | 191.76M | 5.81% | 524,480 | 19.19M |
| 315 | MGNX | MacroGenics, Inc. | 190.67M | -3.85% | 1,027,645 | 149.50M |
| 316 | ARCT | Arcturus Therapeutics Holdings Inc. | 189.87M | -4.57% | 452,647 | 82.03M |
| 317 | TNYA | Tenaya Therapeutics, Inc. | 184.97M | -4.54% | 3,278,884 | - |
| 318 | KRRO | Korro Bio, Inc. | 184.61M | 11.30% | 1,097,434 | 6.39M |
| 319 | WHWK | Whitehawk Therapeutics, Inc. | 184.54M | 0.26% | 217,282 | 7.15M |
| 320 | CRBU | Caribou Biosciences, Inc. | 181.68M | -0.53% | 760,646 | 11.16M |
| 321 | EVAX | Evaxion A/S | 177.65M | 4.55% | 86,851 | 7.53M |
| 322 | TNXP | Tonix Pharmaceuticals Holding Corp. | 177.49M | -1.27% | 423,401 | 13.11M |
| 323 | MIST | Milestone Pharmaceuticals Inc. | 172.69M | -2.86% | 769,343 | - |
| 324 | SGMT | Sagimet Biosciences Inc. | 169.77M | -2.43% | 372,471 | - |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 166.90M | -1.88% | 142,904 | - |
| 326 | HRTX | Heron Therapeutics, Inc. | 166.23M | -4.98% | 2,114,971 | 154.90M |
| 327 | PMN | ProMIS Neurosciences, Inc. | 162.76M | -9.02% | 59,743 | - |
| 328 | KLRS | Kalaris Therapeutics, Inc. | 162.15M | -4.91% | 32,467 | - |
| 329 | ELDN | Eledon Pharmaceuticals, Inc. | 161.22M | -1.10% | 652,503 | - |
| 330 | NKTX | Nkarta, Inc. | 160.53M | -1.31% | 802,149 | - |
| 331 | NBY | NovaBay Pharmaceuticals, Inc. | 158.05M | -4.72% | 186,818 | 10.30M |
| 332 | MOLN | Molecular Partners AG | 157.88M | -10.40% | 13,223 | 856.30K |
| 333 | ARTV | Artiva Biotherapeutics, Inc. | 152.75M | -8.44% | 203,566 | 251.00K |
| 334 | IMUX | Immunic, Inc. | 152.64M | -14.60% | 5,055,802 | - |
| 335 | VXRT | Vaxart, Inc. | 152.48M | -13.84% | - | 237.26M |
| 336 | EQ | Equillium, Inc. | 150.41M | 19.32% | 4,749,044 | 4.39M |
| 337 | CNTB | Connect Biopharma Holdings Limited | 150.38M | -3.93% | 66,875 | 762.00K |
| 338 | IKT | Inhibikase Therapeutics, Inc. | 150.35M | 0.50% | 1,170,561 | 1.00 |
| 339 | MENS | Jyong Biotech Ltd. | 146.98M | -7.91% | 307,226 | - |
| 340 | UNCY | Unicycive Therapeutics, Inc. | 146.79M | -2.57% | 382,716 | - |
| 341 | CDXS | Codexis, Inc. | 146.30M | -5.85% | 6,124,233 | 70.39M |
| 342 | SPRO | Spero Therapeutics, Inc. | 145.36M | -0.39% | 200,360 | 40.55M |
| 343 | KPTI | Karyopharm Therapeutics Inc. | 144.00M | -0.63% | 696,769 | 146.07M |
| 344 | VOR | Vor Biopharma Inc. | 140.65M | -4.06% | 637,192 | - |
| 345 | IPHA | Innate Pharma S.A. | 140.58M | - | 38,792 | 14.84M |
| 346 | OVID | Ovid Therapeutics Inc. | 140.29M | -1.99% | 954,824 | 6.61M |
| 347 | DTIL | Precision BioSciences, Inc. | 140.20M | - | 278,651 | 34.26M |
| 348 | ORMP | Oramed Pharmaceuticals Inc. | 136.52M | 1.48% | 221,755 | 2.00M |
| 349 | FATE | Fate Therapeutics, Inc. | 136.03M | - | 1,860,760 | 6.65M |
| 350 | ANTX | AN2 Therapeutics, Inc. | 135.37M | -9.19% | 629,021 | - |
| 351 | VTVT | vTv Therapeutics Inc. | 131.08M | -1.28% | 143,756 | 17.00K |
| 352 | RANI | Rani Therapeutics Holdings, Inc. | 128.75M | 2.33% | 790,290 | 1.20M |
| 353 | SGMO | Sangamo Therapeutics, Inc. | 127.26M | -4.52% | 4,073,037 | 32.88M |
| 354 | CRDF | Cardiff Oncology, Inc. | 127.16M | -2.62% | 352,625 | 593.00K |
| 355 | ACOG | Alpha Cognition Inc. | 125.02M | -1.71% | 26,969 | 7.43M |
| 356 | BDTX | Black Diamond Therapeutics, Inc. | 120.79M | -0.47% | 978,561 | 70.00M |
| 357 | INO | Inovio Pharmaceuticals, Inc. | 114.69M | -1.19% | 924,613 | 65.34K |
| 358 | AARD | Aardvark Therapeutics, Inc. | 110.83M | -3.23% | 265,601 | - |
| 359 | TTRX | Turn Therapeutics Inc. | 106.30M | -3.09% | 9,757 | - |
| 360 | ONCY | Oncolytics Biotech Inc. | 105.88M | 2.34% | 592,823 | - |
| 361 | AGEN | Agenus Inc. | 105.43M | 4.03% | 313,767 | 106.83M |
| 362 | VRCA | Verrica Pharmaceuticals Inc. | 104.96M | -0.65% | 87,818 | 35.58M |
| 363 | SEER | Seer, Inc. | 102.12M | -0.55% | 230,047 | 16.58M |
| 364 | GOSS | Gossamer Bio, Inc. | 101.17M | -4.98% | 5,999,227 | 44.05M |
| 365 | QTTB | Q32 Bio Inc. | 99.77M | -3.12% | 405,974 | 53.74M |
| 366 | GNLX | Genelux Corporation | 98.93M | -1.14% | 100,605 | 8.00K |
| 367 | HURA | TuHURA Biosciences, Inc. | 97.39M | -3.06% | 940,072 | - |
| 368 | FBIO | Fortress Biotech, Inc. | 96.22M | -5.49% | 499,716 | 62.30M |
| 369 | BMEA | Biomea Fusion, Inc. | 96.16M | -3.55% | 610,259 | - |
| 370 | PYXS | Pyxis Oncology, Inc. | 95.89M | 0.65% | 228,510 | 2.82M |
| 371 | ANIX | Anixa Biosciences, Inc. | 94.88M | -1.05% | 67,927 | - |
| 372 | COYA | Coya Therapeutics, Inc. | 94.79M | -4.63% | 138,103 | 3.99M |
| 373 | CGTX | Cognition Therapeutics, Inc. | 92.69M | -2.78% | 405,367 | - |
| 374 | GANX | Gain Therapeutics, Inc. | 87.72M | -11.64% | 1,263,002 | - |
| 375 | CSBR | Champions Oncology, Inc. | 84.71M | 6.27% | 21,705 | 57.95M |
| 376 | IBIO | iBio, Inc. | 84.63M | -1.61% | 1,176,464 | 300.00K |
| 377 | PLRX | Pliant Therapeutics, Inc. | 83.58M | -4.26% | 684,322 | - |
| 378 | ATYR | aTyr Pharma, Inc. | 83.34M | -2.02% | 785,846 | 190.00K |
| 379 | PMVP | PMV Pharmaceuticals, Inc. | 83.19M | -1.27% | 511,987 | - |
| 380 | MCRB | Seres Therapeutics, Inc. | 82.73M | -4.64% | 38,094 | 789.00K |
| 381 | SPRB | Spruce Biosciences, Inc. | 82.40M | 0.27% | 30,028 | 697.00K |
| 382 | KZIA | Kazia Therapeutics Limited | 81.61M | -6.49% | 87,773 | 1.20M |
| 383 | VANI | Vivani Medical, Inc. | 80.25M | -0.90% | 115,689 | - |
| 384 | PTHS | Pelthos Therapeutics Inc. | 79.27M | 5.38% | 13,121 | 7.41M |
| 385 | PYPD | PolyPid Ltd. | 76.27M | 0.48% | 62,693 | - |
| 386 | NRXS | NeurAxis, Inc. | 73.08M | 5.86% | 511,232 | 3.36M |
| 387 | ANVS | Annovis Bio, Inc. | 71.46M | 2.44% | 236,897 | - |
| 388 | IMMP | Immutep Limited | 71.13M | -82.44% | 46,958,694 | 5.28M |
| 389 | XBIT | XBiotech Inc. | 70.43M | -1.28% | 5,254 | - |
| 390 | ACET | Adicet Bio, Inc. | 69.19M | 2.41% | 146,195 | - |
| 391 | BYSI | BeyondSpring Inc. | 68.16M | 3.68% | 30,691 | 1.88M |
| 392 | MNOV | MediciNova, Inc. | 66.45M | -2.17% | 19,734 | 409.66K |
| 393 | ATHE | Alterity Therapeutics Limited | 65.25M | 1.41% | 2,289 | 4.43M |
| 394 | GRCE | Grace Therapeutics, Inc. | 64.99M | 3.45% | 372,713 | - |
| 395 | COEP | Coeptis Therapeutics Holdings, Inc. | 64.29M | -0.25% | 68,453 | 501.00K |
| 396 | IFRX | InflaRx N.V. | 64.09M | -3.56% | 339,233 | 73.73K |
| 397 | GUTS | Fractyl Health, Inc. | 63.79M | -0.85% | 2,459,921 | 3.00K |
| 398 | IMA | ImageneBio, Inc. | 62.97M | -1.50% | 60,725 | 800.00K |
| 399 | MREO | Mereo BioPharma Group plc | 61.42M | -0.23% | 1,485,380 | 500.00K |
| 400 | EXOZ | eXoZymes, Inc. | 61.23M | 1.25% | 584 | -700.00 |
| 401 | TCRX | TScan Therapeutics, Inc. | 59.75M | -7.08% | 650,947 | 10.33M |
| 402 | ACTU | Actuate Therapeutics, Inc. | 59.50M | 0.39% | 119,346 | - |
| 403 | CING | Cingulate Inc. | 58.72M | -4.71% | 540,207 | - |
| 404 | ENTX | Entera Bio Ltd. | 58.24M | -3.79% | 51,349 | 124.00K |
| 405 | HYFT | MindWalk Holdings Corp. | 57.90M | -5.34% | 374,272 | 18.18M |
| 406 | ICCC | ImmuCell Corporation | 57.62M | -3.92% | 17,283 | 27.64M |
| 407 | RADX | Radiopharm Theranostics Limited | 56.71M | -1.84% | 12,362 | 10.86M |
| 408 | MAIA | MAIA Biotechnology, Inc. | 56.66M | -2.55% | 662,157 | - |
| 409 | TIL | Instil Bio, Inc. | 56.02M | -5.60% | 58,304 | - |
| 410 | MGX | Metagenomi Therapeutics, Inc. | 54.93M | -7.01% | 336,673 | 25.21M |
| 411 | OSTX | OS Therapies Incorporated | 54.58M | 1.97% | 440,731 | - |
| 412 | LPCN | Lipocine Inc. | 53.58M | -8.82% | 163,547 | 1.98M |
| 413 | NRXP | NRx Pharmaceuticals, Inc. | 52.26M | 3.33% | 349,520 | 242.00K |
| 414 | GOVX | GeoVax Labs, Inc. | 51.70M | -7.53% | 30,226 | 3.35M |
| 415 | OKUR | OnKure Therapeutics, Inc. | 51.69M | 7.39% | 272,142 | - |
| 416 | ACRV | Acrivon Therapeutics, Inc. | 51.12M | 0.62% | 727,574 | - |
| 417 | RLYB | Rallybio Corporation | 50.16M | -2.50% | 99,284 | 674.00K |
| 418 | KZR | Kezar Life Sciences, Inc. | 50.16M | -4.60% | 11,014 | - |
| 419 | EDSA | Edesa Biotech, Inc. | 49.76M | -6.58% | 620,173 | - |
| 420 | IBO | Impact BioMedical Inc. | 49.08M | -18.73% | 517,392 | 32.00K |
| 421 | DCOY | Decoy Therapeutics Inc. | 48.62M | 1.74% | 20,757 | - |
| 422 | ESLA | Estrella Immunopharma, Inc. | 47.58M | 0.80% | 22,067 | - |
| 423 | ATRA | Atara Biotherapeutics, Inc. | 46.87M | -5.80% | 171,514 | 151.93M |
| 424 | ALGS | Aligos Therapeutics, Inc. | 46.84M | 2.16% | 40,676 | 2.19M |
| 425 | NXTC | NextCure, Inc. | 46.39M | -3.62% | 22,918 | - |
| 426 | INKT | MiNK Therapeutics, Inc. | 45.72M | -5.25% | 112,344 | - |
| 427 | LSTA | Lisata Therapeutics, Inc. | 45.43M | - | 32,550 | 170.00K |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 45.38M | -5.71% | 57,821 | - |
| 429 | NTRB | Nutriband Inc. | 44.89M | -2.10% | 10,894 | 2.28M |
| 430 | ATOS | Atossa Therapeutics, Inc. | 43.14M | -0.79% | 105,695 | - |
| 431 | LITS | Lite Strategy, Inc. | 42.91M | 2.61% | 248,493 | - |
| 432 | PSTV | Plus Therapeutics, Inc. | 42.89M | -15.17% | 8,265,976 | 5.21M |
| 433 | APLM | Apollomics, Inc. | 42.73M | 0.51% | 542 | 6.93M |
| 434 | PTN | Palatin Technologies, Inc. | 41.01M | 6.62% | 20,497 | 8.96M |
| 435 | SNSE | Sensei Biotherapeutics, Inc. | 40.73M | 3.46% | 161,347 | - |
| 436 | CRVO | CervoMed Inc. | 39.35M | -1.85% | 52,760 | 4.01M |
| 437 | VERU | Veru Inc. | 38.36M | -2.44% | 29,571 | 16.89M |
| 438 | CMMB | Chemomab Therapeutics Ltd. | 37.87M | -1.61% | 23,302 | - |
| 439 | HOWL | Werewolf Therapeutics, Inc. | 37.85M | -5.59% | 300,933 | 1.14M |
| 440 | TVRD | Tvardi Therapeutics, Inc. | 36.77M | 6.67% | 47,898 | - |
| 441 | CELU | Celularity Inc. | 35.18M | -3.94% | 160,156 | 40.58M |
| 442 | INMB | INmune Bio Inc. | 34.83M | -1.50% | 236,865 | 50.00K |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 34.63M | -1.77% | 149,387 | 90.00K |
| 444 | RNTX | Rein Therapeutics Inc. | 34.17M | 1.56% | 44,298 | - |
| 445 | JSPR | Jasper Therapeutics, Inc. | 34.14M | -3.94% | 385,290 | - |
| 446 | PLUR | Pluri Inc. | 34.08M | 8.36% | 3,074 | 1.34M |
| 447 | OTLK | Outlook Therapeutics, Inc. | 32.73M | -6.41% | 1,957,146 | 205.70K |
| 448 | ABVC | ABVC BioPharma, Inc. | 32.31M | -7.30% | 53,454 | 797.92K |
| 449 | PDSB | PDS Biotechnology Corporation | 30.91M | -3.52% | 182,791 | - |
| 450 | RNXT | RenovoRx, Inc. | 30.61M | 3.35% | 409,033 | 928.00K |
| 451 | TPST | Tempest Therapeutics, Inc. | 30.47M | -1.31% | 46,778 | - |
| 452 | BCTX | BriaCell Therapeutics Corp. | 30.45M | -1.86% | 360,287 | - |
| 453 | LONA | LeonaBio, Inc. | 30.21M | 2.13% | 52,862 | - |
| 454 | CVM | CEL-SCI Corporation | 30.19M | 1.42% | 41,589 | - |
| 455 | TLSA | Tiziana Life Sciences Ltd | 28.99M | -3.17% | 131,274 | - |
| 456 | HYPD | Hyperion DeFi, Inc. | 28.91M | 5.00% | 400,067 | 345.32K |
| 457 | NRSN | NeuroSense Therapeutics Ltd. | 28.70M | 1.11% | 37,120 | - |
| 458 | KYNB | Kyntra Bio, Inc. | 28.20M | -0.71% | 19,953 | 8.30M |
| 459 | DYAI | Dyadic International, Inc. | 27.50M | -0.58% | 36,071 | 3.34M |
| 460 | XLO | Xilio Therapeutics, Inc. | 26.78M | -0.23% | 431,166 | 31.80M |
| 461 | XCUR | Exicure, Inc. | 26.77M | 6.60% | 26,849 | 500.00K |
| 462 | LTRN | Lantern Pharma Inc. | 26.73M | -5.14% | 61,026 | - |
| 463 | IGC | IGC Pharma, Inc. | 26.28M | -0.04% | 448,195 | 1.11M |
| 464 | BRNS | Barinthus Biotherapeutics plc | 25.69M | 4.83% | 5,365 | 14.97M |
| 465 | NNVC | NanoViricides, Inc. | 25.48M | 1.72% | 323,381 | - |
| 466 | BOLD | Boundless Bio, Inc. | 24.87M | -0.45% | 42,869 | - |
| 467 | ENLV | Enlivex Ltd. | 24.81M | -2.80% | 105,926 | - |
| 468 | SNTI | Senti Biosciences, Inc. | 24.49M | -6.40% | 126,949 | - |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 24.47M | -4.02% | 117,207 | 14.99M |
| 470 | VTGN | Vistagen Therapeutics, Inc. | 24.06M | -3.73% | 471,390 | 789.00K |
| 471 | PASG | Passage Bio, Inc. | 23.90M | -8.02% | 48,019 | - |
| 472 | CUE | Cue Biopharma, Inc. | 22.34M | -6.74% | 1,144,439 | 7.10M |
| 473 | MRKR | Marker Therapeutics, Inc. | 22.18M | -1.48% | 79,085 | 4.69M |
| 474 | SKYE | Skye Bioscience, Inc. | 22.04M | -6.61% | 307,414 | - |
| 475 | CTXR | Citius Pharmaceuticals, Inc. | 21.53M | 10.92% | 1,318,670 | 3.94M |
| 476 | FBLG | FibroBiologics, Inc. | 21.12M | -8.14% | 790,126 | - |
| 477 | LGVN | Longeveron Inc. | 20.77M | 20.33% | 13,548,522 | 1.44M |
| 478 | DARE | Daré Bioscience, Inc. | 20.58M | -3.38% | 72,689 | -57.13K |
| 479 | ALLR | Allarity Therapeutics, Inc. | 19.92M | -6.67% | 122,836 | - |
| 480 | VYNE | VYNE Therapeutics Inc. | 19.54M | 0.66% | 244,851 | 570.00K |
| 481 | KTTA | Pasithea Therapeutics Corp. | 18.93M | -0.88% | 51,525 | - |
| 482 | INAB | IN8bio, Inc. | 18.61M | 1.57% | 61,134 | - |
| 483 | LIXT | Lixte Biotechnology Holdings, Inc. | 17.74M | -4.01% | 12,233 | - |
| 484 | LEXX | Lexaria Bioscience Corp. | 17.42M | 3.12% | 82,894 | 522.00K |
| 485 | INTS | Intensity Therapeutics, Inc. | 17.18M | -8.63% | 27,815 | - |
| 486 | GNTA | Genenta Science S.p.A. | 16.85M | 1.73% | 17,106 | - |
| 487 | SER | Serina Therapeutics, Inc. | 16.53M | -0.64% | 36,502 | 116.00K |
| 488 | TRAW | Traws Pharma, Inc. | 15.98M | -0.99% | 329,646 | 2.85M |
| 489 | HOTH | Hoth Therapeutics, Inc. | 15.98M | -3.74% | 370,256 | - |
| 490 | CVKD | Cadrenal Therapeutics, Inc. | 15.36M | 3.06% | 25,571 | - |
| 491 | AEON | AEON Biopharma, Inc. | 15.32M | -5.13% | 69,625 | - |
| 492 | JUNS | Jupiter Neurosciences, Inc. | 14.56M | 14.74% | 288,392 | - |
| 493 | COCP | Cocrystal Pharma, Inc. | 14.20M | 1.98% | 20,529 | - |
| 494 | PLRZ | Polyrizon Ltd. | 14.02M | -6.47% | 47,853 | - |
| 495 | IOBT | IO Biotech, Inc. | 13.78M | -13.66% | 6,616,653 | - |
| 496 | PHIO | Phio Pharmaceuticals Corp. | 13.59M | -6.40% | 368,266 | - |
| 497 | CLRB | Cellectar Biosciences, Inc. | 13.57M | -0.93% | 47,710 | - |
| 498 | BCDA | BioCardia, Inc. | 13.37M | -0.79% | 36,699 | 3.00K |
| 499 | GTBP | GT Biopharma, Inc. | 13.08M | -2.47% | 549,092 | - |
| 500 | CALC | CalciMedica, Inc. | 13.07M | 14.33% | 874,080 | - |
| 501 | QNRX | Quoin Pharmaceuticals, Ltd. | 13.03M | -0.37% | 10,263 | - |
| 502 | KAPA | Kairos Pharma, Ltd. | 12.53M | 0.30% | 79,925 | - |
| 503 | NCEL | NewcelX Ltd. | 12.49M | -1.79% | 11,353 | - |
| 504 | PPBT | Purple Biotech Ltd | 12.42M | 6.77% | 15,134 | - |
| 505 | SNGX | Soligenix, Inc. | 12.41M | 0.82% | 175,719 | 2.34K |
| 506 | CRIS | Curis, Inc. | 12.28M | -5.93% | 114,937 | 11.65M |
| 507 | GDTC | CytoMed Therapeutics Limited | 12.23M | -0.93% | 4,182 | 573.19K |
| 508 | OSRH | OSR Holdings, Inc. | 12.07M | -6.00% | 449,546 | -90.52K |
| 509 | BLRX | BioLineRx Ltd. | 11.38M | -1.13% | 7,429 | 12.74M |
| 510 | ACXP | Acurx Pharmaceuticals, Inc. | 11.08M | -22.55% | 5,859,703 | - |
| 511 | BIVI | BioVie Inc. | 10.64M | 1.44% | 49,768 | - |
| 512 | PHGE | BiomX Inc. | 9.87M | -2.83% | 67,068 | - |
| 513 | QNTM | Quantum BioPharma Ltd. | 9.77M | -3.13% | 278,568 | - |
| 514 | BCAB | BioAtla, Inc. | 9.71M | -1.90% | 862,081 | 11.00M |
| 515 | ERNA | Ernexa Therapeutics Inc. | 9.45M | 4.89% | 3,472,848 | 1,000.00 |
| 516 | ICU | SeaStar Medical Holding Corporation | 9.23M | -3.03% | 61,160 | 881.00K |
| 517 | IMNN | Imunon, Inc. | 9.18M | -4.78% | 22,567 | - |
| 518 | ITRM | Iterum Therapeutics plc | 9.11M | 0.82% | 488,620 | 390.00K |
| 519 | RNAZ | TransCode Therapeutics, Inc. | 8.97M | -0.15% | 6,753 | - |
| 520 | ADXN | Addex Therapeutics Ltd | 8.40M | -5.21% | 1,399 | 198.82K |
| 521 | CDIO | Cardio Diagnostics Holdings, Inc. | 8.29M | -38.60% | 1,134,645 | 14.83K |
| 522 | AKTX | Akari Therapeutics, Plc | 8.19M | -10.71% | 929,471 | - |
| 523 | TOVX | Theriva Biologics, Inc. | 8.04M | -3.20% | 1,928,021 | - |
| 524 | ARTL | Artelo Biosciences, Inc. | 7.99M | -3.59% | 22,252 | - |
| 525 | ALZN | Alzamend Neuro, Inc. | 7.76M | -2.39% | 58,334 | - |
| 526 | PULM | Pulmatrix, Inc. | 7.71M | -2.31% | 10,821 | 3.00K |
| 527 | KPRX | Kiora Pharmaceuticals, Inc. | 7.69M | -2.79% | 20,500 | 20.00K |
| 528 | GRDX | GridAI Technologies Corp. | 7.60M | 2.73% | 181,875 | - |
| 529 | BOLT | Bolt Biotherapeutics, Inc. | 7.51M | -3.46% | 29,071 | 7.70M |
| 530 | CLGN | CollPlant Biotechnologies Ltd. | 7.47M | -1.18% | 38,499 | 2.48M |
| 531 | MLEC | Moolec Science SA | 7.43M | -10.34% | 20,572 | 7.83M |
| 532 | TCRT | Alaunos Therapeutics, Inc. | 7.37M | 3.45% | 18,978 | 6.00K |
| 533 | SPRC | SciSparc Ltd. | 7.07M | -7.82% | 55,665 | 1.31M |
| 534 | DWTX | Dogwood Therapeutics, Inc. | 7.02M | 2.66% | 49,784 | - |
| 535 | PMCB | PharmaCyte Biotech, Inc. | 6.99M | -0.69% | 30,250 | - |
| 536 | EVGN | Evogene Ltd. | 6.95M | -1.43% | 186,735 | 3.85M |
| 537 | MBIO | Mustang Bio, Inc. | 6.88M | -0.30% | 28,587 | - |
| 538 | PCSA | Processa Pharmaceuticals, Inc. | 6.68M | 6.88% | 52,000 | - |
| 539 | MBRX | Moleculin Biotech, Inc. | 6.53M | -0.49% | 148,419 | - |
| 540 | XBIO | Xenetic Biosciences, Inc. | 6.43M | 9.46% | 66,499 | 2.98M |
| 541 | IMRN | Immuron Limited | 6.39M | -3.33% | 7,883 | 4.99M |
| 542 | LIMN | Liminatus Pharma, Inc. | 6.31M | -2.10% | 1,622,250 | - |
| 543 | QNCX | Quince Therapeutics, Inc. | 5.93M | - | 16,295,700 | - |
| 544 | CYCN | Cyclerion Therapeutics, Inc. | 5.69M | 2.11% | 18,836 | 2.86M |
| 545 | PBM | Psyence Biomedical Ltd. | 5.64M | - | 3,015 | - |
| 546 | XTLB | XTL Biopharmaceuticals Ltd. | 5.29M | -4.76% | 35,586 | 968.00K |
| 547 | ASBP | Aspire Biopharma Holdings, Inc. | 5.28M | -6.67% | 163,725 | 1.94K |
| 548 | BDRX | Biodexa Pharmaceuticals Plc | 5.15M | -4.14% | 67,448 | 104.90K |
| 549 | APM | Aptorum Group Limited | 5.03M | -1.01% | 9,034 | - |
| 550 | SLXN | Silexion Therapeutics Corp | 5.02M | -3.66% | 27,170 | - |
| 551 | CELZ | Creative Medical Technology Holdings, Inc. | 4.85M | -3.09% | 16,602 | 6.00K |
| 552 | VIVS | VivoSim Labs, Inc. | 4.69M | -3.23% | 42,682 | 142.00K |
| 553 | REVB | Revelation Biosciences, Inc. | 4.67M | 2.06% | 78,429 | - |
| 554 | GNPX | Genprex, Inc. | 4.66M | 2.55% | 682,507 | - |
| 555 | APRE | Aprea Therapeutics, Inc. | 4.64M | -3.79% | 122,726 | 488.24K |
| 556 | LNAI | Lunai Bioworks Inc. | 4.46M | -4.06% | 1,235,785 | - |
| 557 | SILO | Silo Pharma, Inc. | 4.29M | -6.06% | 260,189 | 72.10K |
| 558 | APVO | Aptevo Therapeutics Inc. | 4.14M | -3.28% | 33,527 | - |
| 559 | MTNB | Matinas BioPharma Holdings, Inc. | 4.12M | 0.77% | 8,166 | - |
| 560 | BGMS | Bio Green Med Solution, Inc. | 4.04M | -12.93% | 245,205 | 81.00K |
| 561 | OGEN | Oragenics, Inc. | 3.69M | -7.67% | 400,169 | - |
| 562 | GRI | GRI Bio, Inc. | 3.67M | -13.01% | 62,223 | - |
| 563 | NCNA | NuCana plc | 3.64M | -4.02% | 45,211 | - |
| 564 | GLMD | Galmed Pharmaceuticals Ltd. | 3.45M | -3.20% | 5,003 | - |
| 565 | INDP | Indaptus Therapeutics, Inc. | 3.10M | -1.67% | 14,760 | - |
| 566 | ADIL | Adial Pharmaceuticals, Inc. | 2.80M | 4.81% | 31,242 | - |
| 567 | AZTR | Azitra, Inc. | 2.77M | -5.00% | 1,435,057 | 7.50K |
| 568 | BRTX | BioRestorative Therapies, Inc. | 2.69M | -1.66% | 2,471,185 | 383.40K |
| 569 | ENVB | Enveric Biosciences, Inc. | 2.64M | -1.04% | 22,430 | - |
| 570 | XRTX | XORTX Therapeutics Inc. | 2.58M | -13.31% | 62,413 | - |
| 571 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.53M | -17.87% | 966,455 | 1.36M |
| 572 | LYRA | Lyra Therapeutics, Inc. | 2.34M | -1.49% | 3,220 | 600.00K |
| 573 | KALA | KALA BIO, Inc. | 2.30M | -5.66% | 11,502,138 | - |
| 574 | CLDI | Calidi Biotherapeutics, Inc. | 2.28M | -3.78% | 216,331 | - |
| 575 | SCNI | Scinai Immunotherapeutics Ltd. | 2.24M | -2.68% | 13,557 | 1.15M |
| 576 | BBLG | Bone Biologics Corporation | 2.19M | -3.17% | 14,680 | - |
| 577 | ONCO | Onconetix, Inc. | 1.95M | -5.17% | 38,688 | 815.37K |
| 578 | PPCB | Propanc Biopharma, Inc. | 1.92M | 5.12% | 2,800,610 | - |
| 579 | JAGX | Jaguar Health, Inc. | 1.88M | -7.88% | 461,098 | 11.79M |
| 580 | HCWB | HCW Biologics Inc. | 1.69M | -7.69% | 38,928 | 422.03K |
| 581 | CNSP | CNS Pharmaceuticals, Inc. | 1.51M | -14.08% | 160,977 | - |
| 582 | ENSC | Ensysce Biosciences, Inc. | 1.44M | -6.22% | 289,656 | 4.49M |
| 583 | DRMA | Dermata Therapeutics, Inc. | 1.40M | -4.03% | 98,201 | - |
| 584 | CMND | Clearmind Medicine Inc. | 1.17M | -5.88% | 242,860 | - |
| 585 | ADTX | Aditxt, Inc. | 1.02M | -37.02% | 1,058,964 | 5.95K |
| 586 | OKYO | OKYO Pharma Limited | 955.68K | -2.35% | 32,047 | - |
| 587 | VRAX | Virax Biolabs Group Limited | 829.31K | -0.46% | 84,882 | 2.99K |
| 588 | CDT | CDT Equity Inc. | 779.18K | -18.94% | 251,014 | - |
| 589 | ELAB | PMGC Holdings Inc. | 384.50K | 4.09% | 58,794 | 285.95K |
| 590 | MTVA | MetaVia Inc. | 336.64K | - | 50,405 | - |
| 591 | CANF | Can-Fite BioPharma Ltd. | 20.48K | -3.23% | 53,725 | 560.00K |